Literature DB >> 18453350

The evaluation and preparation of the patient for lung volume reduction surgery.

Malcolm M DeCamp1, David Lipson, Mark Krasna, Omar A Minai, Robert J McKenna, Byron M Thomashow.   

Abstract

Potential candidates for lung volume reduction surgery should undergo extensive evaluation and preparation to minimize perioperative risks and optimize surgical outcomes. Initial screening includes spirometry, diffusion capacity, lung volumes by body plethysmography, and high-resolution computerized tomography scanning. Patients who have been successfully screened must complete a preoperative pulmonary rehabilitation program of 6-10 weeks duration. During the pulmonary rehabilitation program, medical therapy should be maximized. Postrehabilitation studies include cardiopulmonary exercise testing, arterial blood gas analysis, oxygen titration, six-minute walk, and cardiac testing. The evaluation process aims at defining the severity and distribution of emphysema and attempts to eliminate those who do not meet criteria outlined by the National Emphysema Treatment Trial. Optimal candidates have upper-lobe-predominant emphysema and acceptable operative risks.

Entities:  

Mesh:

Year:  2008        PMID: 18453350      PMCID: PMC2645314          DOI: 10.1513/pats.200707-087ET

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  21 in total

1.  Patient and surgical factors influencing air leak after lung volume reduction surgery: lessons learned from the National Emphysema Treatment Trial.

Authors:  Malcolm M DeCamp; Eugene H Blackstone; Keith S Naunheim; Mark J Krasna; Douglas E Wood; Yvonne M Meli; Robert J McKenna
Journal:  Ann Thorac Surg       Date:  2006-07       Impact factor: 4.330

2.  Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease.

Authors:  Selim M Arcasoy; Jason D Christie; Victor A Ferrari; Martin St John Sutton; David A Zisman; Nancy P Blumenthal; Alberto Pochettino; Robert M Kotloff
Journal:  Am J Respir Crit Care Med       Date:  2002-12-12       Impact factor: 21.405

3.  Patients at high risk of death after lung-volume-reduction surgery.

Authors:  Alfred Fishman; Henry Fessler; Fernando Martinez; Robert J McKenna; Keith Naunheim; Steven Piantadosi; Gail Weinmann; Robert Wise
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

4.  Lung volume reduction surgery in patients with emphysema and alpha-1 antitrypsin deficiency.

Authors:  James K Stoller; Thomas R Gildea; Andrew L Ries; Yvonne M Meli; Matthew T Karafa
Journal:  Ann Thorac Surg       Date:  2007-01       Impact factor: 4.330

5.  The BODE index after lung volume reduction surgery correlates with survival.

Authors:  Stephan Imfeld; Konrad E Bloch; Walter Weder; Erich W Russi
Journal:  Chest       Date:  2006-04       Impact factor: 9.410

6.  Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Authors:  Shawn D Aaron; Katherine L Vandemheen; Dean Fergusson; François Maltais; Jean Bourbeau; Roger Goldstein; Meyer Balter; Denis O'Donnell; Andrew McIvor; Sat Sharma; Graham Bishop; John Anthony; Robert Cowie; Stephen Field; Andrew Hirsch; Paul Hernandez; Robert Rivington; Jeremy Road; Victor Hoffstein; Richard Hodder; Darcy Marciniuk; David McCormack; George Fox; Gerard Cox; Henry B Prins; Gordon Ford; Dominique Bleskie; Steve Doucette; Irvin Mayers; Kenneth Chapman; Noe Zamel; Mark FitzGerald
Journal:  Ann Intern Med       Date:  2007-02-19       Impact factor: 25.391

7.  Measures of abstinence in clinical trials: issues and recommendations.

Authors:  John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan
Journal:  Nicotine Tob Res       Date:  2003-02       Impact factor: 4.244

8.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema.

Authors:  Alfred Fishman; Fernando Martinez; Keith Naunheim; Steven Piantadosi; Robert Wise; Andrew Ries; Gail Weinmann; Douglas E Wood
Journal:  N Engl J Med       Date:  2003-05-20       Impact factor: 91.245

9.  Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD.

Authors:  Vincent S Fan; Scott D Ramsey; Barry J Make; Fernando J Martinez
Journal:  COPD       Date:  2007-03       Impact factor: 2.409

10.  Lung-volume reduction surgery for pulmonary emphysema: Improvement in body mass index, airflow obstruction, dyspnea, and exercise capacity index after 1 year.

Authors:  David J Lederer; Byron M Thomashow; Mark E Ginsburg; John H M Austin; Matthew N Bartels; Chun K Yip; Patricia A Jellen; Frances L Brogan; Steven M Kawut; Roger A Maxfield; Angela M DiMango; Paul F Simonelli; Lyall A Gorenstein; Gregory D N Pearson; Joshua R Sonett
Journal:  J Thorac Cardiovasc Surg       Date:  2007-06       Impact factor: 5.209

View more
  4 in total

Review 1.  Lung volume reduction surgery for diffuse emphysema.

Authors:  Joseph Em van Agteren; Kristin V Carson; Leong Ung Tiong; Brian J Smith
Journal:  Cochrane Database Syst Rev       Date:  2016-10-14

Review 2.  Lung volume reduction surgery: nonpharmacological approach.

Authors:  Roberto Benzo
Journal:  Curr Opin Anaesthesiol       Date:  2011-02       Impact factor: 2.706

3.  Non-invasive methods for estimating mPAP in COPD using cardiovascular magnetic resonance imaging.

Authors:  C S Johns; S Rajaram; D A Capener; C Oram; C Elliot; R Condliffe; D G Kiely; J M Wild; A J Swift
Journal:  Eur Radiol       Date:  2017-11-16       Impact factor: 5.315

4.  The Expressions of Hope in the Face of Complex Surgery: Experiences of Patients and Their Loved Ones.

Authors:  Karen M Baur; Jill Chamberlain; M Cecilia Wendler; Paula Harwood; Joni Colle; Deb Yeaman
Journal:  J Patient Exp       Date:  2018-10-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.